HOME > TOP STORIES
TOP STORIES
-
BUSINESS Daiichi Sankyo to Harness Ties with Cardiologists in Lixiana Promotion
December 8, 2014
-
BUSINESS Nippon Chemiphar to Set Up Plant in Vietnam, Operation Launch Slated in 2018
December 5, 2014
-
REGULATORY ICH Makes Progress Toward Greater Inclusivity, Agrees to Establish Assembly at November Meeting in Lisbon
December 4, 2014
-
REGULATORY Pharma Industry Girding for Post-Election Lobbying on R&D Tax Credit
December 3, 2014
-
BUSINESS Otsuka to Buy US Firm Avanir Pharmaceuticals to Fully Enter Neurology Market
December 3, 2014
-
BUSINESS Takeda’s Proteasome Inhibitor Ixazomib Granted Breakthrough Therapy Designation by US FDA
December 3, 2014
-
BUSINESS A-zas Looks to Offer E-Detailing App, Big-Data Analyses to More Firms
December 2, 2014
-
REGULATORY PAFSC’s Second Committee Backs Approval of Novartis’s Secukinumab
December 1, 2014
-
BUSINESS EPS Gives 400 Workers CDISC Training to Set Itself Apart from Rival CROs
November 28, 2014
-
INTERVIEW Gilead Starting from Scratch to Build Solo Sales Regime: Japan Pres.
November 28, 2014
-
ACADEMIA Avigan’s Efficacy in Ebola “Unknown” with No Corroborative Data: NIID Official
November 27, 2014
-
BUSINESS Kaken Banking on Clenafin to Boost Dermatology Biz
November 27, 2014
-
REGULATORY Debates on Yearly NHI Price Cuts Put on Hold as Attention Turns to Election
November 26, 2014
-
REGULATORY PAFSC First Committee Backs Approval of Takeda’s Vonoprazan
November 25, 2014
-
ORGANIZATION JPMA President Opposes Annual NHI Price Revision
November 21, 2014
-
REGULATORY Chuikyo OKs NHI Price Listing of 14 APIs/15 Products
November 20, 2014
-
REGULATORY 3 Straight Years of NHI Price Cuts Loom as Abe Delays Sales Tax Hike, Eyes Now Turned to 2019 and Beyond
November 19, 2014
-
REGULATORY Health Ministry Drug Evaluation Head Calls for Mulling Necessity of PI Studies for Japanese Patients
November 18, 2014
-
REGULATORY PMDA to Accept All Requests for Generic Drug Face-to-Face Consultations
November 17, 2014
-
BUSINESS Combined Half-Year Sales of Major Japanese Drug Makers Up 2.8% Thanks to Overseas Sales
November 14, 2014
ページ
The Japanese healthcare sector is experiencing rapid growth, demanding a highly skilled and diverse workforce. However, finding and attracting the best talent in this competitive market presents significant challenges.Enter AI. With the rise of AI-powered tools, healthcare organizations can revolutionize…
